| Overview of the typhoid conjugate vaccine pipeline: current status and future plans S Sahastrabuddhe, T Saluja Clinical Infectious Diseases 68 (Supplement_1), S22-S26, 2019 | 71 | 2019 |
| The Euvichol story–Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships L Odevall, D Hong, L Digilio, S Sahastrabuddhe, V Mogasale, Y Baik, ... Vaccine 36 (45), 6606-6614, 2018 | 64 | 2018 |
| Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development S Sahastrabuddhe, R Carbis, TF Wierzba, R Leon Ochiai Expert review of vaccines 12 (9), 1021-1031, 2013 | 63 | 2013 |
| Status of paratyphoid fever vaccine research and development LB Martin, R Simon, CA MacLennan, SM Tennant, S Sahastrabuddhe, ... Vaccine 34 (26), 2900-2902, 2016 | 56 | 2016 |
| Sexually transmitted infections and risk behaviors among transgender persons (Hijras) of Pune, India S Sahastrabuddhe, A Gupta, E Stuart, S Godbole, M Ghate, S Sahay, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (1), 72-78, 2012 | 54 | 2012 |
| Review on the recent advances on typhoid vaccine development and challenges ahead KA Syed, T Saluja, H Cho, A Hsiao, H Shaikh, TA Wartel, V Mogasale, ... Clinical Infectious Diseases 71 (Supplement_2), S141-S150, 2020 | 52 | 2020 |
| Typhoid fever surveillance and vaccine use, South-East Asia and Western Pacific Regions, 2009–2013 KA Date, AD Bentsi-Enchill, KK Fox, N Abeysinghe, ED Mintz, MI Khan, ... MMWR Morb Mortal Wkly Rep 63 (39), 855-60, 2014 | 50 | 2014 |
| Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children MR Capeding, S Teshome, T Saluja, KA Syed, DR Kim, JY Park, JS Yang, ... Vaccine 36 (26), 3794-3801, 2018 | 39 | 2018 |
| Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide … BE Medise, S Soedjatmiko, I Rengganis, H Gunardi, R Sekartini, ... PLoS One 14 (2), e0211784, 2019 | 31 | 2019 |
| Spatial and temporal patterns of typhoid and paratyphoid fever outbreaks: a worldwide review, 1990–2018 S Kim, KS Lee, GD Pak, JL Excler, S Sahastrabuddhe, F Marks, JH Kim, ... Clinical Infectious Diseases 69 (Supplement_6), S499-S509, 2019 | 29 | 2019 |
| Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method MS Jang, S Sahastrabuddhe, CH Yun, SH Han, JS Yang Microbial pathogenesis 97, 19-26, 2016 | 26 | 2016 |
| 25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal D Bajracharya, MI Khan, A Pach III, P Shrestha, N Joshi, SR Upreti, ... PloS one 9 (1), e77974, 2014 | 22 | 2014 |
| Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India S Mehendale, S Sahay, M Thakar, S Sahasrabuddhe, M Kakade, A Shete, ... Indian Journal of Medical Research 132 (2), 168-175, 2010 | 20 | 2010 |
| Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: phase II, randomized, dose-scheduling, observer-blind study MR Capeding, A Sil, BT Tadesse, T Saluja, S Teshome, E Alberto, ... EClinicalMedicine 27, 2020 | 19 | 2020 |
| Typhoid vaccine introduction: An evidence-based pilot implementation project in Nepal and Pakistan MI Khan, A Pach 3rd, GM Khan, D Bajracharya, S Sahastrabuddhe, ... Vaccine 33, C62-C67, 2015 | 19 | 2015 |
| Barriers to typhoid fever vaccine access in endemic countries MI Khan, C Franco-Paredes, S Sahastrabuddhe, RL Ochiai, V Mogasale, ... Research and reports in tropical medicine, 37-44, 2017 | 16 | 2017 |
| Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial GK Rai, T Saluja, S Chaudhary, D Tamrakar, P Kanodia, BR Giri, ... The Lancet Infectious diseases 22 (4), 529-540, 2022 | 15 | 2022 |
| Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report MR Capeding, E Alberto, A Sil, T Saluja, S Teshome, DR Kim, JY Park, ... Vaccine 38 (28), 4476-4483, 2020 | 15 | 2020 |
| Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer … JY Song, WS Choi, JY Heo, EJ Kim, JS Lee, DS Jung, SW Kim, KH Park, ... EclinicalMedicine 64, 2023 | 12 | 2023 |
| One-month follow up of a randomized clinical trial-phase II study in 6 to< 24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine BE Medise, S Soedjatmiko, H Gunardi, R Sekartini, HI Satari, ... International Journal of Infectious Diseases 93, 102-107, 2020 | 12 | 2020 |
Jerome H. KimInternational Vaccine InstituteVerified email at ivi.int
